The rapid development of COVID-19 vaccines illustrates what’s possible when federal policy fosters innovation with a real public-private partnership, especially for the health challenges facing America’s more than 54 million older adults. Yet, a number of drug-pricing policy proposals now jeopardize this very model, threatening to limit access to prescription drugs, compromise health equity and slow progress on urgently needed new treatments for age-related chronic conditions.

FT dashboard tracks responses to the growing threat of antimicrobial resistance

The coupled crises of rising rates of drug resistant infections and stagnating antibiotic innovation is especially perilous for Japan and other aging societies, says new report from the Global Coalition on Aging and Health and Global Policy Institute, released during Japan’s AMR Awareness Month. Tokyo, JAPAN (November 18, 2021) – A new report released today…

New York, NEW YORK (November 16, 2021) – The Global Coalition on Aging (GCOA) today released a new report, Shining a Spotlight on Caregiving: Employer Practices Through a Policy Lens. The report links 21st century employer benefits to a new social contract for how to meet growing employee needs in our aging society. The report is sponsored by Bank of America.

New York, NY and Tokyo, JAPAN (October 25, 2021) – The Global Coalition on Aging (GCOA) and the Health and Global Policy Institute (HGPI) today launched a new report identifying incentives for health innovation as a fundamental requirement for economic growth and fiscal sustainability in Japan and other rapidly ageing societies across the Organization for Economic Cooperation and Development (OECD) and worldwide.